News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
201 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21820)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Imprimis Pharma Announces Third Quarter 2017 Results
Gross ophthalmology-related revenue of $4.9M, up over 60% year-over-year.
November 14, 2017
·
15 min read
Biotech Beach
Janssen R&D’s INVOKANA (canagliflozin) Demonstrates Cardiovascular (CV) Risk Reductions in Type 2 Diabetes Patients With and Without a History of Prior CV Events
INVOKANA also achieved similar and proportional risk reductions for hospitalization due to heart failure and renal outcomes in each of the primary and secondary prevention groups.
November 14, 2017
·
15 min read
BioCapital
Akonni Biosystems Awarded NIH Grant to Support Commercialization of a Low-Cost, Simple, Rapid Point-of-Care Test for Tuberculosis and its Resistance to First-Line Drugs
This grant in particular will help Akonni accelerate the commercialization of its proprietary TruArray MDR-TB test on its TruDx 3000 sample-to-answer diagnostic platform.
November 14, 2017
·
3 min read
Policy
FDA Renews and Expands Its Portfolio of Simcyp Simulator (PBPK) Licenses
Certara announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certara’s PBPK Simcyp® Population-based Simulator and its Pediatric and Cardiac Safety Simulators.
November 14, 2017
·
4 min read
Business
FORMA Therapeutics Appoints Christine Bellon, Ph.D., J.D., General Counsel and Corporate Secretary
Chris joins the executive leadership team of FORMA with over 20 years of global experience in legal strategy, corporate partnerships and intellectual property, within the public and private Life Sciences sectors.
November 14, 2017
·
3 min read
Business
U.S. Major General Gale S. Pollock (Ret.) Joins Covalon’s Board of Directors
Major General Pollock is a two-star General who retired in 2008 after 36 years of service in the U.S. Army.
November 14, 2017
·
4 min read
Business
C4 Therapeutics Expands Management Team with Appointment of Ron Kaiser as Chief Financial Officer
He also served on C4T’s Board of Directors from January 2016 until October 2017.
November 14, 2017
·
1 min read
Bio NC
Locus Biosciences Closes $19M Series a Led by ARTIS Ventures for CRISPR-Cas3 Antimicrobials
RTIS Ventures led the round, with additional financing from notable institutional investors Tencent Holdings Limited, Abstract Ventures, and the North Carolina Biotechnology Center, among others.
November 14, 2017
·
3 min read
Business
Spectral Announces Third Quarter Results
Revenue for the three months ended September 30, 2017 was $857,000 compared to $807,000 for the same period in the preceding year.
November 14, 2017
·
15 min read
Biotech Bay
InnerScope Hearing Technologies Announces an Exclusive U.S. Distribution Agreement With Speechlab Advanced Technologies BV, for Rights to Distribute their State of the Art Personal Sound Amplifier Product (PSAP)
InnerScope Hearing Technologies has announced an exclusive U.S. Distribution with Speechlab Advanced Technologies BV. for resell rights of its BlackCat Personal Sound Amplifier Product, which further expands the Company’s PSAP portfolio.
November 14, 2017
·
4 min read
Previous
9 of 21
Next